[[ data.name ]]
[[ data.ticker ]]
[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)
Low: [[ data.low ]]
High: [[ data.high ]]
About
History
Competitors
About
History
Competitors
Inovio Pharmaceuticals (INO.US) is a biotechnology company with a current market capitalization of $150.98 million as of July 20, 2023. Founded in 1979 by Dr. Joseph Kim, Inovio focuses on the discovery, development, and commercialization of innovative immunotherapies to combat infectious diseases and cancer.
The company is known for its expertise in developing DNA-based vaccines and immunotherapies, leveraging its proprietary technology to stimulate the body's immune response. Inovio has been at the forefront of medical advancements, with a strong emphasis on research and development. It went public in 1999 and has since continued to advance its pipeline of promising treatments, aiming to address unmet medical needs and improve global health outcomes.
Inovio's stock price history over the past 5 years has been a bit of a rollercoaster ride. The highest point was reached in June 2020, when the stock price hit $33.79. This was likely due to the announcement of positive results from the company's phase 1 clinical trial for a COVID-19 vaccine, which created a lot of excitement and investor interest in the company.
The lowest point was however reached in June 2023, when the stock price briefly dropped to $0.3825. This was likely due to poor financial performance and negative news related to the company's pipeline of products. When it comes to trading strategies for Inovio's stock, there are several indicators and tools you might want to consider. One such tool is the Moving Average Convergence Divergence (MACD), which may help you identify trends and reversals in the stock price. It's important to note, however, that trading is not without risks and requires careful analysis and planning.
As an investor or trader, one of the key factors to consider before investing your money in any stock is the company's competition. This is because the success of a company is directly linked to its ability to outperform its competitors. So who are its competitors?
- Moderna (MDNA.US): It is a biotech company that specializes in developing mRNA therapeutics and vaccines. They're known for developing one of the first approved COVID-19 vaccines, which has helped spur their growth.
- Pfizer (PFE.US): Pfizer is a pharmaceutical giant that develops and manufactures a wide range of drugs and vaccines. They're known for their extensive research and development capabilities, which have helped them stay ahead of their competition.
Other related competitors you might consider looking into include: Johnson & Johnson (JNJ.US) and AstraZeneca (AZN.SE).
| Swap long | [[ data.swapLong ]] points |
|---|---|
| Swap short | [[ data.swapShort ]] points |
| Spread min | [[ data.stats.minSpread ]] |
| Spread avg | [[ data.stats.avgSpread ]] |
| Min contract size | [[ data.minVolume ]] |
| Min step size | [[ data.stepVolume ]] |
| Commission and Swap | Commission and Swap |
| Leverage | Leverage |
| Trading Hours | Trading Hours |
* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.
The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.
Trade [[data.name]] with Skilling
All Hassle-free, with flexible trade sizes and with zero commissions!*
- Trade 24/5
- Minimum margin requirements
- No commission, only spread
- Fractional shares available
- Easy to use platform
*Other fees may apply.
Why Trade [[data.name]]
Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.
CFDs
Equities
Capitalise on rising prices (go long)
Capitalise on falling prices (go short)
Trade with leverage
Hold larger positions than the cash you have at your disposal
Trade on volatility
No need to own the asset
No commissions
Just low spreads
Manage risk with in-platform tools
Ability to set take profit and stop loss levels